Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CIDEX vs Melphalan and Prednisolone in Relapsed Multiple Myeloma
NCT00003603Phase 3Unknown
- Sponsor
- Riverside Haematology Group
- Start
- Mar 1998
- Modality
- DNA Intercalators/Alkylators, Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of lomustine, idarubicin, dexamethasone in multiple myeloma (MM), sponsored by Riverside Haematology Group. Status: unknown.
02
Drugs
lomustineidarubicindexamethasone
03
Conditions
multiple myeloma (MM)
Beyond the preview
Go deeper on NCT00003603.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00003603.